Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailing Liu

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
BME Frontiers|October 18, 2023
Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer with Deep LearningHailing Liu, Yu Zhao, Fan Yang, et al.
Immunotherapy|March 30, 2021
Identification and functional study of novel oligonucleotides: CpG Seq 13 and CpG Seq 19Hailing Liu, Shan Meng, Nan Yang, et al.
Aging and Disease|February 23, 2023
QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative AnalysisHailing Liu, Zifeng Huang, Bin Deng, et al.
British Journal of Haematology|June 2, 2026
Concurrent antiviral-immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B-cell lymphoma: A multicentre cohort studyYuxiao Zhao, Jingjing Guo, Xiran Wang, et al.
British Journal of Haematology|May 17, 2017
A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapyChenyang Lu, Shan Meng, Yanxia Jin, et al.
Med (New York, N.Y.)|July 31, 2024
A prospective phase 2 study of combination epigenetic therapy against relapsed/refractory peripheral T cell lymphomaKaiyang Ding, Hailing Liu, Haiyan Yang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2019
Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor BurdenChangju Qu, Nana Ping, Liqing Kang, et al.
Leukemia & Lymphoma|June 11, 2025
Progression of disease within 6 months: revised early disease progression threshold for ENKTLMiao Zhong, Hailing Liu, Renfu Gui, et al.
Molecular Cancer|December 21, 2019
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3Tian Lan, Hui Li, Delin Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 21, 2018
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathwayYanxia Jin, Qian Yang, Li Liang, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
BME Frontiers|October 18, 2023
Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer with Deep LearningHailing Liu, Yu Zhao, Fan Yang, et al.
Immunotherapy|March 30, 2021
Identification and functional study of novel oligonucleotides: CpG Seq 13 and CpG Seq 19Hailing Liu, Shan Meng, Nan Yang, et al.
Aging and Disease|February 23, 2023
QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative AnalysisHailing Liu, Zifeng Huang, Bin Deng, et al.
British Journal of Haematology|June 2, 2026
Concurrent antiviral-immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B-cell lymphoma: A multicentre cohort studyYuxiao Zhao, Jingjing Guo, Xiran Wang, et al.
British Journal of Haematology|May 17, 2017
A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapyChenyang Lu, Shan Meng, Yanxia Jin, et al.
Med (New York, N.Y.)|July 31, 2024
A prospective phase 2 study of combination epigenetic therapy against relapsed/refractory peripheral T cell lymphomaKaiyang Ding, Hailing Liu, Haiyan Yang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2019
Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor BurdenChangju Qu, Nana Ping, Liqing Kang, et al.
Leukemia & Lymphoma|June 11, 2025
Progression of disease within 6 months: revised early disease progression threshold for ENKTLMiao Zhong, Hailing Liu, Renfu Gui, et al.
Molecular Cancer|December 21, 2019
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3Tian Lan, Hui Li, Delin Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 21, 2018
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathwayYanxia Jin, Qian Yang, Li Liang, et al.
Pageof 18